110 Einträge gefunden

1. Worst itch numerical rating scale for prurigo nodularis: a psychometric evaluation

   1. Ständer, S
   2. Zeidler, C
   3. Pereira, M
   4. Szepietowski, J C
   5. McLeod, L
   6. Qin, S
   7. Williams, N

   2022 - Forschungsinformationssystem des UKE
2. Assessment of stigma related to visible skin diseases: a systematic review and evaluation of patient-reported outcome measures

   1. Luck-Sikorski, C
   2. Roßmann, P
   3. Topp, J
   4. Augustin, M
   5. Sommer, R
   6. Weinberger, N A

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Secukinumab demonstrated sustained retention, effectiveness and safety in a real-world setting in patients with moderate-to-severe plaque psoriasis: long-term results from an interim analysis of the SERENA study

   1. Augustin, M
   2. Sator, P G
   3. von Kiedrowski, R
   4. Conrad, C
   5. Rigopoulos, D
   6. Romanelli, M
   7. Ghislain, P-D

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Freedom from disease in psoriasis: a Delphi consensus definition by patients, nurses and physicians

   1. van Ee, I
   2. Deprez, E
   3. Egeberg, A
   4. Augustin, M
   5. Conrad, C
   6. Corazza, V
   7. Donati, L

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Development and validation of an outcome instrument measuring dry skin - the Xerosis Area and Severity Index (XASI)

   1. Sommer, R
   2. Augustin, M
   3. da Silva, N
   4. von Stülpnagel, C C

   2022 - Forschungsinformationssystem des UKE
6. Systematic literature review assessing the overall costs and societal impacts of moderate-to-severe atopic dermatitis in Europe

   1. Augustin, M
   2. Misery, L
   3. von Kobyletzski, L
   4. Mealing, S
   5. Redding, M
   6. Chuang, C C
   7. Massey, R

   2022 - Forschungsinformationssystem des UKE
7. A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis

   1. Pinter, A
   2. Green, L J
   3. Selmer, J
   4. Praestegaard, M
   5. Gold, L S
   6. Augustin, M

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
8. Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib

   1. Thyssen, J P
   2. Lio, P
   3. Ball, S
   4. Pierce, E
   5. Sun, L
   6. Chen, Y
   7. Tan, J K L

   2022 - Forschungsinformationssystem des UKE
9. Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe

   1. Augustin, M
   2. Misery, L
   3. von Kobyletzki, L
   4. Armario-Hita, J C
   5. Mealing, S
   6. Redding, M

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
10. Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study

    1. Augustin, M
    2. Kleyn, C E
    3. Conrad, C
    4. Sator, P G
    5. Ståhle, M
    6. Eyerich, K
    7. Radtke, M A

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
11. Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study

    1. Maul, J-T
    2. Augustin, M
    3. Sorbe, C
    4. Conrad, C
    5. Anzengruber, F
    6. Mrowietz, U
    7. Reich, K

    2021 - Forschungsinformationssystem des UKE
12. Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results

    1. Augustin, M
    2. Dauden, E
    3. Mrowietz, U
    4. Konstantinou, M P
    5. Gerdes, S
    6. Kingo, K
    7. Szepietowski, J C

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
13. A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

    1. Pinter, A
    2. Hoffmann, M
    3. Reich, K
    4. Augustin, M
    5. Kaplan, K
    6. Gudjónsdóttir, S D
    7. Delvin, T

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
14. Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

    1. Wollenberg, A
    2. Nakahara, T
    3. Maari, C
    4. Peris, K
    5. Lio, P
    6. Augustin, M
    7. Silverberg, J I

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
15. Significance of chronic pruritus for intrapersonal burden and interpersonal experiences of stigmatization and sexuality in patients with psoriasis

    1. Sommer, R
    2. Augustin, M
    3. Hilbring, C
    4. Ständer, Sonja
    5. Hubo, M
    6. Hutt, H J
    7. von Stülpnagel, C C

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
16. Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

    1. Leutz, A
    2. Pinter, A
    3. Thaçi, D
    4. Augustin, M
    5. Schuster, C
    6. Fotiou, K
    7. Hundemer, H P

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
17. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases - a systematic review

    1. von Stülpnagel, C C
    2. Augustin, M
    3. Düpmann, L
    4. da Silva, N
    5. Sommer, R

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
18. The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non-lesional skin: A comparative, retrospective, explorative statistical analysis of 4,484 patients in a real-world cohort

    1. Zeidler, C
    2. Pereira, M P
    3. Dugas, M
    4. Augustin, M
    5. Storck, M
    6. Weyer-Elberich, V
    7. Schneider, G

    2021 - Forschungsinformationssystem des UKE
19. Stigma in visible skin diseases - A literature review and development of a conceptual model

    1. Germain, N
    2. Augustin, M
    3. François, C
    4. Legau, K
    5. Bogoeva, N
    6. Desroches, M
    7. Toumi, M

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
20. Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study

    1. Reich, K
    2. Sullivan, J
    3. Arenberger, P
    4. Jazayeri, S
    5. Mrowietz, U
    6. Augustin, M
    7. Elewski, B

    2021 - Forschungsinformationssystem des UKE